Products
APIs
Atenolol
Amlodipine Besylate
Metoprolol Succinate
Metoprolol Tartrate
Roxithromycin
Azithromycin
Clarithromycin Granules 27.5%
Clarithromycin Granules 33%
Clarithromycin Granules 43%
Pregabalin
Ceftriaxone Sodium
Cefotaxime Sodium
Cefepime (with L-Arginine) for Injection
Meropenem (with Sodium Carbonate) for Injection
Doripenem
Biapenem
Tebipenem
Lymecycline
Nitroxoline
Category
Anti-Hypertensive
Anti-Hypertensive
Anti-Hypertensive
Anti-Hypertensive
Macrolides
Macrolides
Macrolides
Macrolides
Macrolides
Neuromodulator
Sterile Cephalosporins
Sterile Cephalosporins
Sterile Cephalosporins
Carbapenems
Carbapenems
Carbapenems
Carbapenems
Anti-Acne, Anti-Infective
Urological
Specifications
IP/BP/EP/USP
IP/BP/EP/USP
IP/BP/EP/USP
IP/BP/EP/USP
IP/BP/EP/
IP/BP/EP/USP
In-House
In-House
In-House
IP/EP/In-House
IP/BP/EP/USP
IP/BP/EP/USP
IP/USP
IP/USP
In-House
In-House
In-House
EP
In-House
Regulatory Status
CEP, EU GMP
DMF Available
DMF Available
DMF Available
CEP, KFDA
CEP
DMF Available
…..
DMF Available
EU DMF available and CEP applied
DMF Available
DMF Available
….
DMF Available
DMF Available
DMF Available
….
DMF Available
DMF Available
Products under development
APIs
Ticagrelor
Apixaban
Rivaroxaban
Canagliflozin
Dapagliflozin
Empagliflozin
Imipenem (Non-Sterile)
Ertapenem
Faropenem
Ceftaroline Fosamil
Category
Anti-Thrombotic
Anti-Thrombotic
Anti-Thrombotic
Anti-Diabetic
Anti-Diabetic
Anti-Diabetic
Carbapenems
Carbapenems
Carbapenems
Sterile Cephalosporins
R&D Sample availability
Available
Available
Available
Available
Available
Available
Available
Jun.2020
Available
Apr.2020
Specifications
Apr.2020
Available
Available
Sep. 2020
Apr.2020
Jun.2020
Jun.2020
Apr.2020
Oct. 2019
Aug.2020
R&D Tech pack
IP/ In-House
In-House
In-House
In-House
In-House
In-House
USP
In-House
In-House
In-House